berberine has been researched along with Heart Failure in 8 studies
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to assess the efficacy and safety of berberine for chronic congestive heart failure (CHF)." | 9.10 | Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Li, YY; Zeng, XH; Zeng, XJ, 2003) |
| "To investigate whether CPU86017, a berberine derivative, attenuates heart failure by blocking calcium influx and exerting its antioxidant activity." | 7.76 | CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. ( Cheng, YS; Dai, DZ; Dai, Y; Feng, Y; Li, N; Qi, MY, 2010) |
| "To study the effects of total saponins of Panax ginseng combined with berberine on hemodynamics, Plasma brain natriuretic peptide and Ca2+ concentration in cardiac cells of chronic congestive heart failure rats." | 7.75 | [Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure]. ( Chen, X; Li, G; Li, Y; Liu, H; Luo, F, 2009) |
| "Emerging evidence indicates that leptin may be a potential new target in chronic heart failure (CHF) treatment." | 7.74 | Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. ( Dai, DZ; Dai, Y; Na, T; Tang, XY, 2007) |
| "It has been reported that berberine is valuable for long-term treatment of ventricular premature beats (VPBs) and leads to a decrease in mortality for patients with congestive heart failure (CHF)." | 7.70 | Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. ( Zeng, X, 1999) |
| "Berberine, an alkaloid of the protoberberine family, has been shown to have strong positive inotropic and peripheral resistance-lowering effects in dogs with and without heart failure." | 7.67 | Cardiovascular effects of berberine in patients with severe congestive heart failure. ( Gallo Júnior, L; Maciel, BC; Marin-Neto, JA; Secches, AL, 1988) |
| "This study was designed to assess the efficacy and safety of berberine for chronic congestive heart failure (CHF)." | 5.10 | Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Li, YY; Zeng, XH; Zeng, XJ, 2003) |
| "To investigate whether CPU86017, a berberine derivative, attenuates heart failure by blocking calcium influx and exerting its antioxidant activity." | 3.76 | CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. ( Cheng, YS; Dai, DZ; Dai, Y; Feng, Y; Li, N; Qi, MY, 2010) |
| "To study the effects of total saponins of Panax ginseng combined with berberine on hemodynamics, Plasma brain natriuretic peptide and Ca2+ concentration in cardiac cells of chronic congestive heart failure rats." | 3.75 | [Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure]. ( Chen, X; Li, G; Li, Y; Liu, H; Luo, F, 2009) |
| "Emerging evidence indicates that leptin may be a potential new target in chronic heart failure (CHF) treatment." | 3.74 | Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. ( Dai, DZ; Dai, Y; Na, T; Tang, XY, 2007) |
| "It has been reported that berberine is valuable for long-term treatment of ventricular premature beats (VPBs) and leads to a decrease in mortality for patients with congestive heart failure (CHF)." | 3.70 | Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. ( Zeng, X, 1999) |
| "Berberine, an alkaloid of the protoberberine family, has been shown to have strong positive inotropic and peripheral resistance-lowering effects in dogs with and without heart failure." | 3.67 | Cardiovascular effects of berberine in patients with severe congestive heart failure. ( Gallo Júnior, L; Maciel, BC; Marin-Neto, JA; Secches, AL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YW | 1 |
| Li, XD | 1 |
| Sun, MJ | 1 |
| Liu, ZP | 1 |
| Liu, SW | 1 |
| Li, Y | 1 |
| Chen, X | 1 |
| Liu, H | 1 |
| Luo, F | 1 |
| Li, G | 1 |
| Qi, MY | 1 |
| Feng, Y | 1 |
| Dai, DZ | 2 |
| Li, N | 1 |
| Cheng, YS | 1 |
| Dai, Y | 2 |
| Zeng, XH | 1 |
| Zeng, XJ | 1 |
| Li, YY | 1 |
| Na, T | 1 |
| Tang, XY | 1 |
| Yang, SY | 1 |
| Zeng, X | 2 |
| Marin-Neto, JA | 1 |
| Maciel, BC | 1 |
| Secches, AL | 1 |
| Gallo Júnior, L | 1 |
1 review available for berberine and Heart Failure
| Article | Year |
|---|---|
[Study on inotropic action of berberine].
Topics: Animals; Berberine; Cyclic AMP; Heart Failure; Humans; Myocardial Contraction; Stimulation, Chemical | 1994 |
1 trial available for berberine and Heart Failure
| Article | Year |
|---|---|
Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Aged; Aged, 80 and over; Berberine; Cardiomyopathy, Dilated; Double-Blind Method; Exercise Test; Fem | 2003 |
6 other studies available for berberine and Heart Failure
| Article | Year |
|---|---|
[Protective effects of berberine against exhaustion exercise induced myocardial injury in rats].
Topics: Animals; Berberine; Heart Failure; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2019 |
[Effects of ginseng total saponins with berberine on plasma brain natriuretic peptide and Ca2+ concentration in experimental rats with chronic congestive heart failure].
Topics: Animals; Berberine; Calcium; Disease Models, Animal; Heart Failure; Hemodynamics; Male; Natriuretic | 2009 |
CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity.
Topics: Animals; Antioxidants; Base Sequence; Berberine; Calcium; Calcium-Binding Proteins; DNA Primers; Dow | 2010 |
Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017.
Topics: Alkyl and Aryl Transferases; Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartic Acid Endopeptid | 2007 |
Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC.
Topics: Aged; Anticoagulants; Berberine; Blood Pressure; Chromatography, High Pressure Liquid; Chronic Disea | 1999 |
Cardiovascular effects of berberine in patients with severe congestive heart failure.
Topics: Adult; Aged; Berberine; Berberine Alkaloids; Echocardiography; Electrocardiography; Female; Heart Fa | 1988 |